Real-world evaluation of attention deficit hyperactivity disorder symptoms and side effects in patients prescribed serdexmethylphenidate/dexmethylphenidate or other stimulants

CONCLUSION: In this single-center retrospective analysis of patient surveys, patients with ADHD taking SDX/d-MPH reported reduced frequency of insomnia compared to AMP ER and LDX, and lower frequency of end-of-dose crash compared to AMP ER. This real-world tolerability analysis highlights the importance of considering side effects in ADHD treatment.

via https://pubmed.ncbi.nlm.nih.gov/42256406/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1L37KAMf2b_g4WEK3LmdFuKZu9pO3cN7u4ZmO9PPCPeBLMIw1q&fc=None&ff=20260616010905&v=2.20.0